Tirzepatide, a recently approved medication, is generating considerable interest within the medical community. It functions differently from existing diabetes therapies , targeting two receptors involved in sugar regulation and hunger . Initial studies have demonstrated remarkable efficacy in reducing blood glucose in individuals with type 2 diabet